apomorphine has been researched along with olanzapine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Pettersson, F; Pontén, H; Sonesson, C; Waters, N; Waters, S | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bączek, T; Belka, M; Bojarski, A; Herold, F; Kleps, J; Kozioł, AE; Król, M; Nowak, G; Siwek, A; Ślifirski, G; Stachowicz, K; Szewczyk, B; Turło, J; Ulenberg, S | 1 |
| Bączek, T; Belka, M; Bojarski, A; Herold, F; Kleps, J; Kozioł, AE; Król, M; Nowak, G; Podsadni, P; Siwek, A; Ślifirski, G; Stachowicz, K; Szewczyk, B; Turło, J | 1 |
| Axton, MS; Moore, NA; Risius, FC; Tye, NC | 1 |
| Burger, JE; Czachura, JF; Gates, MR; Rasmussen, K | 1 |
| Kulkarni, SK; Ninan, I | 2 |
| Alper, RH; Gilliland, SL | 1 |
| Breese, GR; Knapp, DJ; Moy, SS | 1 |
| Ahnaou, A; Drinkenburg, WH; Megens, AA | 1 |
| Chopde, CT; Hirani, K; Morelli, M; Ugale, RR | 1 |
| Dall'Olio, R; Gandolfi, O; Locchi, F; Rimondini, R; Voltattorni, M | 1 |
| Kost, NV; Meshavkin, VK; Myasoedov, NF; Sokolov, OY; Zolotarev, YA; Zozulya, AA | 1 |
| Azar, MR; Geyer, MA; Gold, L; Marston, HM; Martin, FD; Meltzer, LT; Moore, CL; Serpa, KA; Shahid, M; Wong, EH; Young, JW | 1 |
| Atack, J; Cik, M; De Bruyn, M; Hendrickx, H; Langlois, X; Lavreysen, H; Macdonald, G; Megens, A; Peeters, L; te Riele, P; Vermeire, J; Wouters, R | 1 |
| Carey, RJ; Carrera, MP; de Matos, LW; Dias, FR; Dos Santos Sampaio, Mde F | 1 |
| Carey, RJ; Carrera, MP; de Fátima Dos Santos Sampaio, M; de Mello Bastos, JM; Dias, FR | 1 |
| Bhatt, KK; Gaikwad, RV; Patel, BG; Patel, MR; Patel, RB | 1 |
1 review(s) available for apomorphine and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
21 other study(ies) available for apomorphine and olanzapine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Cell Line; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Humans; Ligands; Male; Models, Chemical; Molecular Structure; Motor Activity; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
Topics: Animals; Chemistry Techniques, Synthetic; Drug Design; Ligands; Mice; Pyrimidines; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Tryptamines | 2019 |
Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
Topics: Animals; Cells, Cultured; Crystallography, X-Ray; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Ligands; Male; Mice; Models, Molecular; Molecular Structure; Pyrimidines; Rats; Receptor, Serotonin, 5-HT1A; RNA-Binding Proteins; Structure-Activity Relationship; Tryptamines | 2019 |
The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Benzodiazepines; Catalepsy; Conflict, Psychological; Discrimination Learning; Female; Male; Mice; Olanzapine; Pirenzepine; Rats; Rats, Inbred Strains | 1992 |
The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Olanzapine; Pirenzepine; Pyrazoles; Rats; Reflex, Startle | 1997 |
Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Locomotion; Male; Mice; Mice, Inbred BALB C; Motor Activity; Olanzapine; Pirenzepine; Stereotyped Behavior; Stereotypic Movement Disorder | 1999 |
Antagonism by pimozide of olanzapine-induced hypothermia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Azepines; Benzazepines; Benzodiazepines; Body Temperature; Dopamine Agonists; Dopamine Antagonists; Hypothermia; Male; Olanzapine; Pimozide; Pirenzepine; Rats; Rats, Wistar | 1999 |
Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays.
Topics: Animals; Apomorphine; Benzodiazepines; Binding, Competitive; CHO Cells; Clozapine; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Olanzapine; Pirenzepine; Radioligand Assay; Receptors, Dopamine; Selective Serotonin Reuptake Inhibitors; Sulfur Radioisotopes; Transfection | 2000 |
Effect of olanzapine on functional responses from sensitized D1-dopamine receptors in rats with neonatal dopamine loss.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Animals, Newborn; Antipsychotic Agents; Apomorphine; Benzodiazepines; Corpus Striatum; Dopamine; Dopamine Agonists; Female; Male; Motor Activity; Olanzapine; Oxidopamine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2001 |
The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Clozapine; Conscious Sedation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Electroencephalography; Fourier Analysis; Hypnotics and Sedatives; Male; Olanzapine; Pirenzepine; Rats; Rats, Wistar; Risperidone; Stereotyped Behavior; Time Factors | 2003 |
Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Benzodiazepines; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Haloperidol; Injections, Intraventricular; Male; Motor Activity; Neurotransmitter Agents; Olanzapine; Pregnanolone; Rats; Rats, Sprague-Dawley; Risperidone; Social Isolation | 2004 |
An ionotropic but not a metabotropic glutamate agonist potentiates the pharmacological effects of olanzapine in the rat.
Topics: Amphetamines; Animals; Apomorphine; Benzodiazepines; Cycloserine; Dopamine Agonists; Drug Synergism; Excitatory Amino Acid Agonists; Exploratory Behavior; Glycine; Injections, Intraventricular; Male; Motor Activity; Olanzapine; Phenylacetates; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Selective Serotonin Reuptake Inhibitors; Stereotyped Behavior | 2005 |
Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system.
Topics: Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Dopamine; Enkephalin, Leucine-2-Alanine; Male; Mice; Naloxone; Olanzapine; Oligopeptides; Receptors, Dopamine D2; Receptors, Opioid, mu; Spiperone; Stereotyped Behavior | 2006 |
Asenapine effects in animal models of psychosis and cognitive function.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Attention; Benzodiazepines; Cognition; Dibenzocycloheptenes; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Male; Olanzapine; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Risperidone | 2009 |
Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Brain; Catalepsy; Cells, Cultured; CHO Cells; Cricetinae; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Ligands; Locomotion; Male; Olanzapine; Piperidines; Prolactin; Pyridazines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D2; Schizophrenia; Serotonin | 2012 |
Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Conditioning, Psychological; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Motor Activity; Olanzapine; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2013 |
Opposite effects of typical and atypical anti-psychotic drugs on sensitized dopamine receptors: sub-chronic low dose Olanzapine exposure reverses sensitization but a similar regimen of low dose haloperidol potentiates sensitization effects.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Conditioning, Psychological; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Olanzapine; Rats; Rats, Wistar | 2013 |
Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration.
Topics: Administration, Intranasal; Administration, Intravenous; Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Brain; Chemistry, Pharmaceutical; Compulsive Behavior; Drug Delivery Systems; Emulsions; Male; Mice; Motor Activity; Olanzapine; Rabbits; Radionuclide Imaging; Rats; Rats, Wistar; Technetium; Tissue Distribution | 2016 |